Showing 2881-2890 of 20414 results for "".
- Illuminate PRP Adds Industry Veteran Redmond as CCOhttps://reachmd.com/news/illuminate-prp-adds-industry-veteran-redmond-cco/2470885/Industry veteran Jennifer Redmond, MBA, joined Illuminate PRP as Chief Commercial Officer, the company announced. “Jennifer brings a wealth of experience in sales and marketing within the aesthetics and pharmaceutical industries, along with strong leadership and a commitment to driving pos
- Identifying Genetic Keys to Osteoarthritishttps://reachmd.com/news/identifying-genetic-keys-osteoarthritis/2470879/What's New Researchers have identified 13 genes that significantly increase the risk of developing osteoarthritis, potentially opening paths to targeted therapies. Significance Understanding genetic factors in osteoarthritis is essential for developi
- New Data Reveals GLP-1 Medications Impact on Medical Aesthetics Growthhttps://reachmd.com/news/new-data-reveals-glp-1-medications-impact-on-medical-aesthetics-growth/2473724/Guidepoint Qsight revealed new insights Thursday on the state of the $17.5 billion medical aesthetics industry, which was up 2% in 2024. The findings highlight how the integration of glucagon-like peptide-1 (GLP-1) medications for weight loss is reshaping the aesthetics market. GLP-1 medic
- AI and the Future of Glaucoma Treatment through RIPK3 Inhibitionhttps://reachmd.com/news/ai-and-future-glaucoma-treatment-through-ripk3-inhibition/2470881/What's New Researchers have utilized AI to discover RIPK3 inhibitors, offering new hope for glaucoma treatments. Significance Glaucoma affects millions worldwide, with AI offering a potential breakthrough in identifying effective treatments.
- AI Techniques Refine IVF Follicle Monitoring for Improved Outcomeshttps://reachmd.com/news/ai-techniques-refine-ivf-follicle-monitoring-improved-outcomes/2470876/What's New Researchers from Imperial College London have utilized explainable AI to refine the monitoring of follicle sizes in IVF treatments, yielding improved outcomes for patients struggling with infertility. Significance A novel application of Ex
- Higher WWI Linked to Increased Mortality Rates in Psoriasis Patientshttps://reachmd.com/news/higher-wwi-linked-increased-mortality-rates-psoriasis-patients/2470869/New research indicates a strong positive correlation between weight-adjusted waist index (WWI) and all-cause mortality in psoriasis patients. Researchers at Wenzhou Medical University in China published “Weight-Adjusted Waist Index, Psoriasis, and All-Cause Mortality: Findings from the NHA
- The Role of Intermittent Fasting in Weight Loss and Cardiovascular Health: New Findingshttps://reachmd.com/news/role-intermittent-fasting-weight-loss-and-cardiovascular-health-new-findings/2470867/What's New A recent study sheds light on how intermittent fasting can serve as a viable strategy for weight loss and improved cardiovascular health, specifically in individuals battling obesity. Significance This research is of critical importance be
- Navigating Cytomegalovirus Risks in Immunocompromised ICU Patientshttps://reachmd.com/news/navigating-cytomegalovirus-risks-immunocompromised-icu-patients/2470866/What's New Cytomegalovirus (CMV) infection is a formidable challenge for critically ill, immunocompromised patients in intensive care units. Recent insights into its management are crucial for improving patient outcomes. Significance Healthcare profe
- AI-Enhanced Endoscope Improves Precision in Cancer Surgeryhttps://reachmd.com/news/ai-enhanced-endoscope-improves-precision-cancer-surgery/2470859/What's New A groundbreaking AI-integrated endoscope could revolutionize cancer surgery by allowing real-time tumor identification and removal, enhancing surgical precision and patient outcomes. Significance This development is significant as it repre
- COVID-19 Infection Not Linked to Worsening Symptoms in People With MShttps://reachmd.com/news/covid-19-infection-not-linked-to-worsening-symptoms-in-people-with-ms/2470825/For people living with multiple sclerosis (MS), a COVID-19 infection is not associated with worsening MS symptoms or disability, according to a new study published in the December 23, 2024, online issue of Neurology. The findings, which provide reassurance for patients, suggest that COVI